Alexandra Elayne Smith

Alexandra Smith practices at Grand Strand Medical Center in Myrtle Beach, South Carolina, part of HCA Healthcare.

Alexandra Smith's NPI, 1679150528, was assigned on March 26, 2021. Alexandra Smith holds South Carolina license 85690.

Alexandra Smith's primary practice is Grand Strand Medical Center, at 809 82nd Parkway, Myrtle Beach, SC 29572 in Horry County. The practice phone is (843) 692-1000.

Alexandra Smith's primary practice is Grand Strand Medical Center in Myrtle Beach, South Carolina, part of HCA Healthcare. The medical group on file is Southeastern Hospitalist Services.

Dmand AI tracks the electronic health record (EHR) system at each site where Alexandra Smith practices. Vendor and product names are available with a free account.

Internal medicine is Alexandra Smith's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Alexandra Smith is licensed in South Carolina.

CMS data shows 277 Medicare services from Alexandra Smith across 4 procedure codes in 2024, for 133 Medicare patients. Medicare paid $22,182 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 133 Medicare patients who saw Alexandra Smith in 2024. The largest group is 75 to 84, with 53 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Alexandra Smith's median patient age at 72, with 49% women.

In 2024, Alexandra Smith wrote 469 Medicare Part D claims for 152 patients. 90% of them were for generic drugs. CMS names the drug for 176 of them, across 10 drugs with 11 or more claims each, at $10,500 in total drug cost. In 2023, CMS named 53 claims across 3 drugs.

Alexandra Smith accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Alexandra Smith from 3 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Inari Medical, Inc. paid the most, $271.